Skip to content
healthcare.dev

Xatmep

NDC 52652-2001, Methotrexate, solution, from Azurity Pharmaceuticals, Inc..

Product NDC
52652-2001
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208400
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52652-2001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE2.5 mg/mL

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
52652-2001-152652200101120 mL in 1 BOTTLE (52652-2001-1)
52652-2001-65265220010660 mL in 1 BOTTLE (52652-2001-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aec9984e-34c5-481b-b6bf-9bb5caf1daf8
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=52652-2001
  • NADAC price for package 52652200106

    GET /v1/drugs/nadac/52652200106

Use it

Look up 52652-2001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52652-2001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52652-2001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.